- Home
- HUBB vs RVMD Comparison
HUBB vs RVMD Comparison
Compare HUBB & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUBB | RVMD |
|---|---|---|
| Founded | 1888 | 2014 |
| Country | United States | United States |
| Employees | N/A | 883 |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.5B | 19.1B |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | HUBB | RVMD |
|---|---|---|
| Price | $481.82 | $93.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 18 |
| Target Price | ★ $520.38 | $117.33 |
| AVG Volume (30 Days) | 532.6K | ★ 1.6M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.13% | N/A |
| EPS Growth | ★ 15.10 | N/A |
| EPS | ★ 16.54 | N/A |
| Revenue | ★ $5,844,600,000.00 | N/A |
| Revenue This Year | $10.31 | N/A |
| Revenue Next Year | $5.43 | $408.69 |
| P/E Ratio | $30.48 | ★ N/A |
| Revenue Growth | ★ 3.84 | N/A |
| 52 Week Low | $299.43 | $29.17 |
| 52 Week High | $533.80 | $124.49 |
Technical Indicators
Market Signals| Indicator | HUBB | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.16 | 39.13 |
| Support Level | $472.14 | $74.64 |
| Resistance Level | $505.77 | $107.45 |
| Average True Range (ATR) | 16.75 | 3.15 |
| MACD | 1.65 | -0.50 |
| Stochastic Oscillator | 37.47 | 10.06 |
Price Performance
Historical ComparisonAbout HUBB Hubbell Inc
Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, in electrical substations, and in commercial and industrial buildings. The company's primary operations are in the United States, where around 90% of revenue is derived.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.